Limin Group Co., Ltd. Class A
002734.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.15B
Close$
$18.37
43.9% upside
Current Fair Value
43.9% upsideUndervalued by 43.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $6.15 Billion |
|---|---|
| Enterprise Value | $7.28 Billion |
| Dividend Yield | $0.45 (3.45%) |
| Earnings per Share | $1.09 |
| Beta | 0.77 |
| Outstanding Shares | 471,623,514 |
Return
| Return on Equity | 12.04% |
|---|---|
| Return on Assets | 6.97% |
| Return on Invested Capital | 13.04% |
Valuation & Multiples
| P/E Ratio | 12.3 |
|---|---|
| PEG | -104.55 |
| Price to Sales | 1.42 |
| Price to Book Ratio | 1.6 |
| Enterprise Value to Revenue | 1.61 |
| Enterprise Value to EBIT | 12.42 |
| Enterprise Value to Net Income | 15 |
| Total Debt to Enterprise | 0.3 |
| Debt to Equity | 0.54 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 18, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
October 27, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Limin Group Co., Ltd. Class A
4,593 employees
CEO: Jing Quan Sun Limin Group Co.,Ltd. engages in the research and development, production, and sale of fungicides, insecticides, herbicides, and biopesticides in China. The company offers various pesticides, including mancozeb, cymoxanil, fosetyl-aluminu...